Cite
HARVARD Citation
Feng, L. et al. (2021). Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clinical science. 135 (21), pp. 2483-2502. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feng, L. et al. (2021). Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clinical science. 135 (21), pp. 2483-2502. [Online].